Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma

2 Views
administrator
administrator
07/17/23

Howard L. Kaufman, MD, FACS, chief surgical officer and associate director for clinical science at Rutgers Cancer Institute of New Jersey, discusses the adverse event profile of avelumab (Bavencio) for patients with Merkel cell carcinoma.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next